Company intelligence / Profile preview
Binnopharm Group
Moscow, Moscow Region, Russiaen.binnopharmgroup.ru ↗
- Ownership
- Private
- Employees
- ~233
- Development stage
- Other
01
Overview
Binnopharm Group is a top 3 Russian pharmaceutical company with one of the largest drug portfolios in Russia, manufacturing over 240 medicines on the national List of Vital and Essential Medicines. It is fully commercial with a wide range of generic and branded drugs, including biotech and original drugs, actively supplying hospitals and retail and exporting to over 14 countries.[1][2][3][4]
- Therapeutic areas
- EndocrinologyInfectious DiseasesCardiovascularOtherNeurology
- Modalities
- Small moleculeBiologicVaccineRecombinant protein
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Dr. Reddy's (acquisition of antibacterial brands)
Beyond the preview
Go deeper on Binnopharm Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Binnopharm Group.